Industry News
Elizabeth Barrett Browning's Illness Deciphered After 150 Years As Hypokalemic Periodic Paralysis
Dec 21, 2011
Known for her poetry, letters, love affair and marriage to Robert Browning, Elizabeth Barrett Browning also left a legacy of unanswered questions about her lifelong chronic illness. Now, a Penn State anthropologist, with the aid of her daughter, may have unraveled the mystery... Read More
Requiring Less Blood After Surgery
Dec 20, 2011
According to study published in the New England Journal of Medicine, individuals who receive surgery require less blood after the procedure than commonly thought. The study compared two strategies for administering blood transfusions after surgery... Read More
Multiple Myeloma Phase III Trial - Vorinostat Achieved Primary Endpoint
Dec 20, 2011
MSD announced the results of their Phase III study of vorinostat at the 53rd Annual Meeting of the American Society of Hematology (ASH)... Read More
Key Genetic Mutations In Family Of Blood Cancers
Dec 20, 2011
A study published online in Nature Genetics reveals that scientists at the Washington University School of Medicine in St. Louis have uncovered a critical genetic mutation in some patients with myelodysplastic syndromes, which is are blood cancers that can progress to a fatal form of leukemia... Read More
Sunless Tanning Product Users Sunbathe Less
Dec 20, 2011
Young adult females who use tanning lotions and other sunless tanning products tend to sunbathe and use tanning salons less than other women of their age, researchers from Emory University School of Medicine, Atlanta, Georgia, reported in Archives of Dermatology. They added that the more a woman used sunless tanning products, the less she tended to sunbathe or use tanning salons... Read More
Roche's Personalized Medicine Zelboraf Receives Positive Opinion From European Authority For The Treatment Of People With BRAF
Dec 20, 2011
Roche (SIX: RO, ROG; OTCQX: RHHBY), announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended that Zelboraf be granted full marketing authorization as a monotherapy for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma... Read More
Tissue Structure Delays Cancer Development
Dec 20, 2011
Cancer growth normally follows a lengthy period of development. Over the course of time, genetic mutations often accumulate in cells, leading first to pre-cancerous conditions and ultimately to tumour growth... Read More
Pediatric Cancer Survivors May Develop Heart Problems Later
Dec 20, 2011
Will a drug used to treat childhood acute lymphoblastic leukemia and other pediatric cancers cause heart problems later in life? UB associate professor of pharmaceutical sciences, Javier G. Blanco, PhD, who sees his work as a bridge between research and clinical practice, has focused recent efforts on trying to answer this question... Read More
Clues That Could Improve Therapy Revealed By First Comprehensive DNA Study Of Mast Cell Leukemia
Dec 20, 2011
Cancer researchers at Cold Spring Harbor Laboratory (CSHL) have carried out the first comprehensive study of the changes seen in the DNA of a patient with mast cell leukemia (MCL), an extremely aggressive subtype of acute myeloid leukemia (AML) with a very poor prognosis... Read More
Potential To Double The Efficacy Of Radiation Therapy
Dec 20, 2011
Scientists may have a way to double the efficacy and reduce the side effects of radiation therapy. Georgia Health Sciences University scientists have devised a way to reduce lung cancer cells' ability to repair the lethal double-strand DNA breaks caused by radiation therapy. "Radiation is a great therapy - the problem is the side effects," said Dr. William S... Read More
Previous Page Next Page